Visual Snow Syndrome After Start of Citalopram-novel Insights into Underlying Pathophysiology

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 2020 Sep 17

PMID 32939564

Citations 11

Authors

Ozan E Eren

Florian Schoberl

Christoph J Schankin

Andreas Straube

Affiliations

Soon will be listed here.

Citing Articles

[Characterization of a German cohort with visual snow syndrome].

Fay F, Straube A, Ruscheweyh R, Eren O Nervenarzt. 2024; 95(12):1124-1130.

PMID: 39532711 DOI: 10.1007/s00115-024-01768-5.

Neuroimaging in Visual Snow - A Review of the Literature.

Raviskanthan S, Ray J, Mortensen P, Lee A Front Ophthalmol (Lausanne). 2024; 2:758963.

PMID: 38983561 PMC: 11182151. DOI: 10.3389/fopht.2022.758963.

How do I recognise and manage visual snow syndrome?.

Fraser C Eye (Lond). 2024; 38(12):2253-2256.

PMID: 38627546 PMC: 11306332. DOI: 10.1038/s41433-024-03059-4.

Alterations of the alpha rhythm in visual snow syndrome: a case-control study.

Klein A, Aeschlimann S, Zubler F, Scutelnic A, Riederer F, Ertl M J Headache Pain. 2024; 25(1):53.

PMID: 38584260 PMC: 11000394. DOI: 10.1186/s10194-024-01754-x.

Visual snow syndrome: recent advances in understanding the pathophysiology and potential treatment approaches.

Aeschlimann S, Klein A, Schankin C Curr Opin Neurol. 2024; 37(3):283-288.

PMID: 38465699 PMC: 11064904. DOI: 10.1097/WCO.0000000000001258.

References

Schankin C, Maniyar F, Digre K, Goadsby P . 'Visual snow' - a disorder distinct from persistent migraine aura. Brain. 2014; 137(Pt 5):1419-28. DOI: 10.1093/brain/awu050. View

Gallagher R, Kirkham J, Mason J, Bird K, Williamson P, Nunn A . Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. PLoS One. 2011; 6(12):e28096. PMC: 3237416. DOI: 10.1371/journal.pone.0028096. View

Schankin C, Maniyar F, Sprenger T, Chou D, Eller M, Goadsby P . The relation between migraine, typical migraine aura and "visual snow". Headache. 2014; 54(6):957-66. DOI: 10.1111/head.12378. View

Halpern J, Pope Jr H . Hallucinogen persisting perception disorder: what do we know after 50 years?. Drug Alcohol Depend. 2003; 69(2):109-19. DOI: 10.1016/s0376-8716(02)00306-x. View

Abraham H, Aldridge A, Gogia P . The psychopharmacology of hallucinogens. Neuropsychopharmacology. 1996; 14(4):285-98. DOI: 10.1016/0893-133X(95)00136-2. View